Trial Profile
Phase I trial of AIM 102 in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Oct 2012
Price :
$35
*
At a glance
- Drugs AIM 102 (Primary)
- Indications Asthma
- Focus Adverse reactions; Pharmacokinetics
- 03 Jun 2011 New trial record